Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis

Summary

The purpose of this study is to determine the safety and tolerability of intramuscular injections of VM202 at different injection sites in people with amyotrophic lateral sclerosis.

Timeline

Start

2014-03-11

Primary completion

2015-08-03

Completion

2024-03-06

Publications

• Background Sufit RL, Ajroud-Driss S, Casey P, Kessler JA. Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):269-278. doi: 10.1080/21678421.2016.1259334. Epub 2017 Feb 6.

Drugs

Indications